pSMAD2/3, the essential co-partner of active TGFβ signalling, best distinguished invasive SCCs from papillomas, suggesting that RUNX1 and AP1 may prime these chromatin peaks while TGFβ signalling drives their activation. Here, TGFB1 is linked to papilloma.